Novonesis, DK0060336014

Novonesis stock after-hours at EUR 55.94: minus 2.31 percent versus prior close

Published on 09/29/2026 at 22:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novonesis stock was at EUR 55.94 after-hours at 10:07 p.m. CEST on September 29, 2026, down 2.31 percent versus the prior close at Lang & Schwarz.

Industrieanlage mit Fermentationstanks eines daenischen Biotech-Unternehmens
Fotorealistische Ansicht einer Biotech-Anlage von Novonesis (Novozymes), ISIN DK0060336014, mit modernen Fermentationstanks in Bagsvaerd, Illustration mit AI erstellt.

Novonesis stock was at EUR 55.94 after-hours at 10:07 p.m. CEST on September 29, 2026, down EUR 1.32, or 2.31 percent, versus the EUR 57.26 prior close at Lang & Schwarz.

Trading day in focus

The euro-denominated Lang & Schwarz quote was recorded after the Xetra close. The bid was EUR 55.78 and the ask was EUR 56.10.

West Allis expansion completed

On September 28, 2026, Novonesis announced the completion of a major expansion at its West Allis, Wisconsin, production facility. According to the company’s GlobeNewswire release, the project increased fermentation capacity for dairy cultures by approximately 66% and packaging capacity by 17%. The site employs 360 people and supplies cultures to dairy manufacturers across North America.

India investment remains in focus

In a September 2, 2026 release, Novonesis said it would invest EUR 600 million to expand its Patalganga site in India and build an enzyme production facility. The company said the facility is expected to be fully operational in 2030 and will produce enzymes for industries including biofuels, household care, and food and beverages, according to its investor-relations release.

Disclaimer...

en | DK0060336014 | NOVONESIS | boerse | 70200874 | bgmi